Literature DB >> 10191292

Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.

N de Bont1, M G Netea, P N Demacker, I Verschueren, B J Kullberg, K W van Dijk, J W van der Meer, A F Stalenhoef.   

Abstract

Lipoproteins are able to neutralize bacterial lipopolysaccharide (LPS) and thereby inhibit the proinflammatory cytokine response. In a previous study, we demonstrated that hypercholesterolemic low density lipoprotein receptor knock-out (LDLr-/-) mice are protected against lethal endotoxemia and gram-negative infection. In the present study we investigated the susceptibility of apolipoprotein E knock-out mice (apoE-/-) to LPS and to Klebsiella pneumoniae. These mice have increased plasma lipoprotein concentrations in the very low density lipoprotein (VLDL)-sized fraction. Despite 8 -fold higher plasma cholesterol levels compared to controls, and in contrast to LDLr-/- mice, apoE-/- mice were significantly more susceptible to endotoxemia and to K. pneumoniae infection. Circulating TNFalpha concentrations after intravenously injected LPS were 4 - to 5-fold higher in apoE-/- mice, whereas IL-1alpha, IL-1beta, and IL-6 did not differ. This TNF response was not due to an increased cytokine production capacity of cells from apoE-/- mice, as ex vivo cytokine production in response to LPS did not differ between apoE-/- and control mice. The LPS-neutralizing capacity of apoE-/- plasma was significantly less than that of controls. Most likely, the absence of apoE itself in the knock-out mice explains the failure to neutralize LPS, despite the very high cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191292

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  62 in total

1.  Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity.

Authors:  Gregory W Martens; Therese Vallerskog; Hardy Kornfeld
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

2.  New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.

Authors:  Walid F Elkhatib; Pamela S Hair; Julius O Nyalwidhe; Kenji M Cunnion
Journal:  J Med Microbiol       Date:  2015-04       Impact factor: 2.472

Review 3.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Is hypercholesterolemia a friend or a foe of tuberculosis?

Authors:  Runlin Han; Hardy Kornfeld; Gregory Martens
Journal:  Infect Immun       Date:  2009-08       Impact factor: 3.441

Review 5.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

6.  Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.

Authors:  Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

7.  Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis.

Authors:  Go Haraguchi; Hisanori Kosuge; Yasuhiro Maejima; Jun-Ichi Suzuki; Takasuke Imai; Masayuki Yoshida; Mitsuaki Isobe
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

Review 8.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31

Review 9.  NKT cells in sepsis.

Authors:  Briana Leung; Hobart W Harris
Journal:  Clin Dev Immunol       Date:  2010-10-04

10.  Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study.

Authors:  Alexander M Kulminski; Nalini Raghavachari; Konstantin G Arbeev; Irina Culminskaya; Liubov Arbeeva; Deqing Wu; Svetlana V Ukraintseva; Kaare Christensen; Anatoliy I Yashin
Journal:  Biogerontology       Date:  2016-07-22       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.